Allscripts Appoints Vice President and Managing Director, EMEA

AllscriptsAllscripts (NASDAQ: MDRX) has appointed a new leader for its business in the UK while strengthening its focus on Europe, the Middle East and Africa. Richard Strong, who was Vice President, International Services, is taking up the new role of vice president and managing director, EMEA.

Strong said his first priorities for the coming year would be to increase the number of NHS trusts signed-up to deploy the Sunrise electronic patient record and to raise awareness of the capabilities of its dbMotion population health management solution.

He said he would also be looking to bring new clinical and departmental systems to the UK, while taking elements of the UK approach to the Middle East, where there is keen interest in population health management, as well as in administrative and clinical systems.

"Allscripts is well-established in the UK and popular with ourcustomers," he said. "I am looking forward to building onthe excellent work we have already achievedwithin the region with the Global Digital Exemplar programme in the UK and with customers that have benefited from our clinical wrap approach."

"I want more people to hear about what Allscripts has delivered at some of the top performing trusts in the United Kingdom, which use dbMotion to share information with GPs and explore population health management. As we develop our strategy for EMEA, I want more organisations to benefit from the solutions that we are already deploying across the UK."

Strong started his career in the NHS in London, where his work as a biomedical scientist drew him into the implementation of laboratory information systems. He went on to work for Siemens Healthcare Systems and then Cerner UK, where he played a key role in the implementation of electronic patient record systems in the capital, before becoming its director of European services.

He also worked in both UK and international roles for Dell, before joining Allscripts in 2016, to help grow its global ambitions.

Alan Fowles, President Allscripts International, said: "The creation of the new role of vice president and managing director, EMEA, shows our commitment to growing Allscripts as a global company."

"Richard's background in the health tech industry, and his deep understanding of the requirements of health and care organisations in the UK, across Europe, and in the Middle East makes him the ideal choice for the role, and we are confident that this will enable more organisations to benefit from Allscripts’ sector-leading solutions, knowledge and experience."

Allscripts' rapid expansion and high levels of customer satisfaction were recognised in a 2018 KLAS performance report on the European electronic record market, which noted that it had gone from one Sunrise customer in 2011 to eight when the report was written.

The company is currently running a clinical wrap campaign to support trusts that want to digitise without the cost and disruption caused by scrapping their existing patient administration systems and other IT investments.

This is in line with the NHS Long Term Plan’s recognition to complete the digitisation of hospitals through an extension of the GDE programme and an accelerated roll-out of EPRs. The plan also gave strong support to the development and deployment of population health management.

Some of the additional products that Allscripts will be bringing to the UK from other regions include Sunrise Surgical Care with iPro Anaesthesia, the Patient Flow with Census Logic hospital status application, and Follow My Health, a patient engagement platform, as well as integrated electronic document management.

About Allscripts

Allscripts (NASDAQ: MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers to make better decisions and deliver better care for healthier populations.

Most Popular Now

AI-Powered CRISPR could Lead to Faster G…

Stanford Medicine researchers have developed an artificial intelligence (AI) tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing “copilot” supported by AI to help...

Groundbreaking AI Aims to Speed Lifesavi…

To solve a problem, we have to see it clearly. Whether it’s an infection by a novel virus or memory-stealing plaques forming in the brains of Alzheimer’s patients, visualizing disease processes...

AI Spots Hidden Signs of Depression in S…

Depression is one of the most common mental health challenges, but its early signs are often overlooked. It is often linked to reduced facial expressivity. However, whether mild depression or...

ChatGPT 4o Therapeutic Chatbot 'Ama…

One of the first randomized controlled trials assessing the effectiveness of a large language model (LLM) chatbot 'Amanda' for relationship support shows that a single session of chatbot therapy...

AI Tools Help Predict Severe Asthma Risk…

Mayo Clinic researchers have developed artificial intelligence (AI) tools that help identify which children with asthma face the highest risk of serious asthma exacerbation and acute respiratory infections. The study...

AI Model Forecasts Disease Risk Decades …

Imagine a future where your medical history could help predict what health conditions you might face in the next two decades. Researchers have developed a generative AI model that uses...

AI Distinguishes Glioblastoma from Look-…

A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found in the brain but with different origins, behaviors, and treatments. The...

AI Model Indicates Four out of Ten Breas…

A project at Lund University in Sweden has trained an AI model to identify breast cancer patients who could be spared from axillary surgery. The model analyses previously unutilised information...

Smart Device Uses AI and Bioelectronics …

As a wound heals, it goes through several stages: clotting to stop bleeding, immune system response, scabbing, and scarring. A wearable device called "a-Heal," designed by engineers at the University...

Overcoming the AI Applicability Crisis a…

Opinion Article by Harry Lykostratis, Chief Executive, Open Medical. The government’s 10 Year Health Plan makes a lot of the potential of AI-software to support clinical decision making, improve productivity, and...

Dartford and Gravesham Implements Clinis…

Dartford and Gravesham NHS Trust has taken a significant step towards a more digital future by rolling out electronic test ordering using Clinisys ICE. The trust deployed the order communications...